Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 12, 2026
TickeronGET DAILY SIGNALS
Quhuo Limited (QUCY) Declines -48% in 30 Days Amid Ongoing Delisting Concerns

Quhuo Limited (QUCY) Declines -48% in 30 Days Amid Ongoing Delisting Concerns

Key Takeaways

  • QUCY fell roughly 48% over the last 30 days, from about $1.12 (October 13) to approximately $0.58 (November 12).
  • The decline extends a longer downtrend, with shares down roughly 60% over the trailing three months.
  • Quhuo Limited is a China-based gig-economy platform focused on local life services, spanning on-demand delivery, mobility, and housekeeping.
  • A Nasdaq delisting determination announced in April 2026 remains the central overhang weighing on the stock.
  • Thin trading liquidity and elevated volatility have amplified downward price swings in recent weeks.

Quhuo Limited (QUCY) Company Background

Quhuo Limited is a leading gig-economy platform focused on local life services in China. Through its proprietary technology infrastructure, Quhuo+, the company connects and manages workers while providing end-to-end operational solutions to local service providers. Its operations span three primary areas: on-demand delivery solutions for prepared food, grocery, and fresh items; mobility service solutions, including ride-hailing, shared-bike maintenance, and vehicle exports; and housekeeping and accommodation solutions for hotels and short-term rental properties. Founded in 2012 and headquartered in Beijing, Quhuo generates the largest share of its revenue from its on-demand delivery segment. Investors follow the stock for its exposure to China's on-demand services economy, though its small market capitalization and concentrated float contribute to significant price volatility. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Quhuo Limited (QUCY) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, QUCY declined from approximately $1.12 to around $0.58, a drop of roughly 48%. The decline was not linear; the stock briefly traded near $1.40 in early October before breaking down sharply through the middle of the month and continuing lower into November.

The quarterly picture is similarly negative. Measured against a closing level near $1.44 about three months earlier, QUCY has fallen roughly 60%, indicating that the recent 30-day slide is an extension of a broader, multi-month downtrend rather than an isolated event. The persistent downward trajectory reflects sustained selling pressure with limited offsetting buying interest.

Factors Behind the Recent 30-Day Slide in QUCY

The most significant factor weighing on QUCY has been the Nasdaq delisting determination the company disclosed in April 2026. The continued uncertainty around the company's exchange listing status has dampened investor confidence and reduced institutional participation. With a small market capitalization and limited daily trading volume, even modest selling pressure can produce outsized percentage moves, and the absence of a meaningful positive catalyst left the stock vulnerable to sustained declines. Broader sentiment toward small-cap Chinese issuers, combined with thin liquidity in QUCY specifically, has compounded the downward pressure.

Drivers of QUCY Performance Over the Last Quarter

Over the trailing three months, the dominant narrative has been the company's regulatory and listing-status challenges. The April 2026 delisting determination reshaped how investors value the stock, shifting focus toward balance-sheet durability and the company's ability to maintain a trading market for its shares. While Quhuo has pursued growth initiatives—including a strategic partnership focused on blockchain technology and digital-currency strategies to support its international vehicle-export business—these developments have not been sufficient to offset the overhang created by the delisting process. The result has been a steady erosion in the share price as liquidity thinned and risk appetite for the name remained subdued. From what I see, this is important because it highlights how listing concerns can overshadow operational progress.

What to Watch Next for QUCY

Investors monitoring QUCY should pay close attention to any updates on the Nasdaq delisting process and the company's plans for maintaining a trading market for its shares. Further financial disclosures, including revenue trends across the on-demand delivery, mobility, and housekeeping segments, will help clarify the health of the underlying business. Developments in the company's international vehicle-export and blockchain initiatives may also influence sentiment, as could broader regulatory conditions affecting Chinese issuers on U.S. exchanges. Given the stock's thin liquidity, position sizing and volatility management remain important considerations, though none of this constitutes financial advice. I’m watching this closely for any signs of stabilization.

Exploring Tickeron’s AI Trend Prediction Engine

One tool I find particularly useful when analyzing volatile names like this is Tickeron’s AI Trend Prediction Engine. It helps me quickly assess potential movements based on historical patterns and current data, which has been helpful in understanding the recent swings in QUCY. This approach adds a layer of systematic insight to my review process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: QUCY

Momentum Indicator for QUCY turns negative, indicating new downward trend

QUCY saw its Momentum Indicator move below the 0 level on October 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 109 similar instances where the indicator turned negative. In 106 of the 109 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for QUCY turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In 38 of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

QUCY moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for QUCY moved below the 200-day moving average on November 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for QUCY entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +12.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUCY advanced for three days, in 152 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

QUCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.957) is normal, around the industry mean (67.298). P/E Ratio (-0.444) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. QUCY's P/S Ratio (60.976) is very high in comparison to the industry average of (9.775).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. QUCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 20.94B. The market cap for tickers in the group ranges from 27 to 4.39T. MKYSF holds the highest valuation in this group at 4.39T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -0%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 37%. FLGT experienced the highest price growth at 31%, while BDSX experienced the biggest fall at -53%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was -77%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 51
Price Growth Rating: 45
SMR Rating: 78
Profit Risk Rating: 85
Seasonality Score: 22 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Industry
N/A
Address
Robert Koch Strasse 50
Phone
+49 61315542860
Employees
13
Web
http://quantum-cyber.ai
Interact to see
Advertisement
BZ dropped sharply, sliding from a $16.72 prior close to $13.48 (-19.38%), with the decline beginning in premarket and deepening into the early regular session. No verified company-specific news or fundamental catalyst was issued; the fall tracked a broad China ADR selloff (the Nasdaq Golden Dragon index slid more than 2%), but that alone is too small to explain a ~20% drop — the stock's Hong Kong listing fell only -2.6%.
Nebius Group N.V. is expected to report third-quarter 2026 results in early November, following a second quarter in which revenue surged 454% year over year. Wall Street consensus tracked by Benzinga points to roughly $937 million in Q3 2026 revenue, up from $146.1 million in the year-ago quarter.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.